Abstract:Lung adenocarcinoma, a type of non-small cell lung cancer, is the leading cause of cancer death worldwide. Great efforts have been made to identify the underlying mechanism of adenocarcinoma, especially in relation to oncogenes. The present study by integrating computational analysis with western blotting, aimed to understand the role of the upregulation of glucosamine-phosphate N-acetyltransferase 1 (GNPNAT1) in carcinogenesis. In the present study, publicly available gene expression profiles and clinical data were downloaded from The Cancer Genome Atlas to determine the role of GNPNAT1 in lung adenocarcinoma (LUAD). In addition, the association between LUAD susceptibility and GNPNAT1 upregulation were analyzed using Wilcoxon signed-rank test and logistic regression analysis. In LUAD, GNPNAT1 upregulation was significantly associated with disease stage [odds ratio (OR)=2.92, stage III vs. stage I], vital status (dead vs. alive, OR=1.89), cancer status (tumor status vs. tumor-free status, OR=1.85) and N classification (yes vs. no, OR=1.75). Cox regression analysis and the Kaplan-Meier method were utilized to evaluate the association between GNPNAT1 expression and overall survival (OS) time in patients with LUAD. The results demonstrated that patients with increased GNPNAT1 expression levels exhibited a reduced survival rate compared with those with decreased expression levels (P=8.9×10−5). In addition, Cox regression analysis revealed that GNPNAT1 upregulation was significantly associated with poor OS time [hazard ratio (HR): 1.07; 95% confidence interval (CI): 1.04–1.10; P<0.001]. The gene set enrichment analysis revealed that ‘cell cycle’, ‘oocyte meiosis’, ‘pyrimidine mediated metabolism’, ‘ubiquitin mediated proteolysis’, ‘one carbon pool by folate’, ‘mismatch repair progesterone-mediated oocyte maturation’ and ‘basal transcription factors purine metabolism’ were differentially enriched in the GNPNAT1 high-expression samples compared with GNPNAT1 low-expression samples. The aforementioned pathways are involved in the pathogenesis of LUAD. The findings of the present study suggested that GNPNAT1 upregulation may be considered as a promising diagnostic and prognostic biomarker in patients with LUAD. In addition, the aforementioned pathways may be pivotal pathways perturbed by the abnormal expression of GNPNAT1 in LUAD. The findings of the present study demonstrated the therapeutic value of the regulation of GNPNAT1 in lung adenocarcinoma.

Oncogenic zinc finger protein <scp>ZNF687</scp> accelerates lung adenocarcinoma cell proliferation and tumor progression by activating the <scp>PI3K</scp>/<scp>AKT</scp> signaling pathway

Oncogenic zinc finger protein ZNF687 accelerates lung adenocarcinoma cell proliferation and tumor progression by activating the PI3K/AKT signaling pathway

ZNF692 Promotes Proliferation and Cell Mobility in Lung Adenocarcinoma

SLC39A5 Promotes Lung Adenocarcinoma Cell Proliferation by Activating PI3K/AKT Signaling

ZNF671 Inhibits the Proliferation and Metastasis of NSCLC via the Wnt/β-Catenin Pathway

ZEB1-activated LINC01123 Accelerates the Malignancy in Lung Adenocarcinoma Through NOTCH Signaling Pathway.

UHMK1 Promotes Lung Adenocarcinoma Oncogenesis by Regulating the PI3K/AKT/mTOR Signaling Pathway

ZNF692 promotes colon adenocarcinoma cell growth and metastasis by activating the PI3K/AKT pathway

ZNF251 Promotes the Progression of Lung Cancer by Activating ERK Signaling.

Plakophilin-2 Promotes Lung Adenocarcinoma Development Via Enhancing Focal Adhesion and Epithelial–Mesenchymal Transition

Enhanced Expression of Long Non-Coding RNA ZXF1 Promoted the Invasion and Metastasis in Lung Adenocarcinoma.

ATF1 promotes malignancy of lung adenocarcinoma cells through transcriptionally regulating ZNF143 expression

POC1A promotes lung adenocarcinoma progression through the PI3K/AKT pathway and is a potential prognostic marker

PLEK2 activates the PI3K/AKT signaling pathway to drive lung adenocarcinoma progression by upregulating SPC25

ATF1 Promotes the Malignancy of Lung Adenocarcinoma Cells by Transcriptionally Regulating ZNF143 Expression.

Identification and Validation of LINC01322 As a Potential Prognostic Biomarker and Oncogene Promoting Tumor Progression in Lung Adenocarcinoma.

Upregulation of Glucosamine-Phosphate N-acetyltransferase 1 is a Promising Diagnostic and Predictive Indicator for Poor Survival in Patients with Lung Adenocarcinoma

Overexpression of zinc finger protein 687 enhances tumorigenic capability and promotes recurrence of hepatocellular carcinoma

Activation of circ_0072088/ miR ‐1261/ PIK3CA pathway accelerates lung adenocarcinoma progression

Cancer/testis antigen LDHC promotes proliferation and metastasis by activating the PI3K/Akt/GSK-3β-signaling pathway and the in lung adenocarcinoma

Silencing of ZNF610 suppresses cell proliferation and migration in lung adenocarcinoma